@ $7.58
Issued: 27 jan 2023 @ 15:39
Return: -1.32%
Previous signal: Jan 27 - 15:31
Previous signal:
Return: -0.26 %

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer...
Stats | |
---|---|
Current Price | $7.48 |
Today's Volume | 169 049T |
Average Volume | 230 855T |
Market Cap | 116.07M |
EPS | 0.0100 |
P/E | 748.00 |
ATR14 | $0.019 (0.25%) |